These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 339229)

  • 21. Clofazimine-resistant M. leprae.
    Levy L
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary dapsone resistance in leprosy.
    Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
    Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary dapsone resistance in China.
    Chen JK; Wang SY; Hou YH; Ni GX; Zhang JL; Tang QG
    Lepr Rev; 1989 Dec; 60(4):263-6. PubMed ID: 2691789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
    Chang YT
    Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug susceptibility testing of Mycobacterium leprae.
    Baohong J
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
    Dhople AM
    Int J Antimicrob Agents; 1999 Aug; 12(4):319-23. PubMed ID: 10493608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of desoxy fructo serotonin (DFS) on the multiplication of M. leprae in mouse foot-pad.
    Balakrishnan S; Mester L; Venkataramanaiah HN; Bhatia VN
    Lepr India; 1982 Jan; 54(1):56-8. PubMed ID: 7047899
    [No Abstract]   [Full Text] [Related]  

  • 30. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
    Floch HA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 34. Dapsone resistance in North India.
    Sreevatsa ; Girdhar BK; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(3):514-8. PubMed ID: 3913706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary dapsone-resistant leprosy in Brazil: a preliminary report.
    dos Santos Damasco MH; Talhari S; Viana SM; Signorelli M; Saad MH; Andrade LM
    Lepr Rev; 1986 Mar; 57(1):5-8. PubMed ID: 3517536
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of radiometric macrophage assay and the mouse foot pad infection for the evaluation of Mycobacterium leprae sensitivity/resistance to dapsone.
    Sathish M; Rees RJ; Seshadri PS; Nath I
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):378-84. PubMed ID: 3900244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 38. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
    Pattyn SR
    Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
    [No Abstract]   [Full Text] [Related]  

  • 39. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Sensitivity of Mycobacterium leprae to dapsone, studied in the rat.
    Pattyn SR; Verdoolaeghe-Van Loo G
    Int J Lepr Other Mycobact Dis; 1974; 42(1):72-3. PubMed ID: 4606751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.